DAWN
USDDay One Biopharmaceuticals Inc. Common Stock
$7.300+0.040 (0.551%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$7.260
High
$7.490
Low
$7.108
Volume
10.46M
Company Fundamentals
Market Cap
747.8M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.49M
Exchange
NMS
Currency
USD
52-Week Range
Low $5.635Current $7.300High $16.76
Related News
GlobeNewswire
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
Commercial execution delivers best quarter launch-to-date with growth across all dimensions of core business Raising OJEMDA full-year 2025 net product revenue guidance to $145 to $150 million Three-year FIREFLY-1 data
View more
GlobeNewswire
Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025
BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (NASDAQ:DAWN) ("Day One" or the "Company"), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.